Diabetic Retinopathy Market Predicted to Grow at 6.30% CAGR, Reaching USD 15.23 Billion by 2032 | PMR

𝐀𝐜𝐜𝐨𝐫𝐝𝐢𝐧𝐠 𝐭𝐨 𝐭𝐡𝐞 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭, 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐝𝐢𝐚𝐛𝐞𝐭𝐢𝐜 𝐫𝐞𝐭𝐢𝐧𝐨𝐩𝐚𝐭𝐡𝐲 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 𝟖.𝟕𝟔 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑 𝐚𝐧𝐝 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 𝟏𝟓.𝟐𝟑 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟔.𝟑𝟎% 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝.

Diabetic retinopathy is a complication of diabetes that affects the eyes. The eye condition involves the development of abnormal blood vessels in the retina. Complications due to diabetic retinopathy may cause serious vision problems and even lead to blindness in people with diabetes. The early symptoms of the condition include floaters, blurriness and dark vision areas.

𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐡𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:
https://www.polarismarketresearch.com/industry-analysis/diabetic-retinopathy-market/request-for-sample

Also, individuals with diabetic retinopathy may experience difficulty perceiving colors. The mild cases of the condition may be treated with careful diabetes management. Advanced cases of the condition may need laser treatment or surgery.

𝐊𝐞𝐲 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐏𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐧𝐭𝐬

The top industry participants are focused on improving their product offerings through product upgrades and strategic collaborations. Also, these players focus on getting regulatory approvals to expand their customer base. Additionally, acquisitions are being considered as a potential growth strategy. Among the top industry participants include:

• Bayer
• Allergan
• Novartis
• Oxurion
• Sirnaomics
• Genentech
• Alimera Sciences
• Ampio Pharmaceuticals
• BCN Peptides
• Kowa Company

𝐆𝐫𝐨𝐰𝐭𝐡 𝐅𝐚𝐜𝐭𝐨𝐫𝐬 𝐚𝐧𝐝 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬

• Diabetes is a major global health concern that leads to health complications such as diabetic retinopathy. The growing emphasis on the effective management of diabetes is one of the major factors driving the market forward.

• The growing geriatric population and rising incidences of blindness associated with diabetes are creating strong market demand for products aimed at diabetes management.

• The diabetic retinopathy market growth is influenced by the increasing awareness among people about the importance of diabetes management and the need for effective solutions.

𝐆𝐞𝐭 𝐀𝐡𝐞𝐚𝐝 𝐰𝐢𝐭𝐡 𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:
https://www.polarismarketresearch.com/buy/2587/2

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰

𝐃𝐢𝐚𝐛𝐞𝐭𝐢𝐜 𝐑𝐞𝐭𝐢𝐧𝐨𝐩𝐚𝐭𝐡𝐲, 𝐓𝐲𝐩𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞 - 𝐔𝐒𝐃 𝐁𝐢𝐥𝐥𝐢𝐨𝐧, 𝟐𝟎𝟏𝟗 - 𝟐𝟎𝟑𝟐)
• Proliferative Diabetic Retinopathy
• Non-proliferative diabetic retinopathy

𝐃𝐢𝐚𝐛𝐞𝐭𝐢𝐜 𝐑𝐞𝐭𝐢𝐧𝐨𝐩𝐚𝐭𝐡𝐲, 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞 - 𝐔𝐒𝐃 𝐁𝐢𝐥𝐥𝐢𝐨𝐧, 𝟐𝟎𝟏𝟗 - 𝟐𝟎𝟑𝟐)
• Anti-VEGF
• Intraocular Steroid Injection
• Laser Surgery
• Vitrectomy

𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬:

𝐑𝐢𝐬𝐢𝐧𝐠 𝐃𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐏𝐫𝐞𝐯𝐚𝐥𝐞𝐧𝐜𝐞:The increasing prevalence of diabetes worldwide, driven by factors such as sedentary lifestyles, unhealthy diets, and aging populations, is a significant driver of the diabetic retinopathy market.

𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬:Continuous advancements in diagnostic imaging technologies, such as optical coherence tomography (OCT) and fundus photography, improve the early detection and monitoring of diabetic retinopathy, driving market growth.

𝐆𝐫𝐨𝐰𝐢𝐧𝐠 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐚𝐧𝐝 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐏𝐫𝐨𝐠𝐫𝐚𝐦𝐬: Increasing awareness about the importance of regular eye screenings for people with diabetes, coupled with government-led screening programs and initiatives by healthcare organizations, contribute to early diagnosis and treatment of diabetic retinopathy.

𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐬 𝐢𝐧 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐎𝐩𝐭𝐢𝐨𝐧𝐬: The development of novel treatments for diabetic retinopathy, including anti-VEGF injections, laser therapy, and corticosteroid implants, offers improved outcomes and vision preservation for patients, driving market growth.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐃𝐞𝐭𝐚𝐢𝐥𝐬:
https://www.polarismarketresearch.com/industry-analysis/diabetic-retinopathy-market

𝐃𝐢𝐚𝐛𝐞𝐭𝐢𝐜 𝐑𝐞𝐭𝐢𝐧𝐨𝐩𝐚𝐭𝐡𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

• Non-proliferative diabetic retinopathy segment accounted for highest global market share in 2022, due to rise in number of cases of diabetes

• Anti-VEGF segment accounted largest share, due its high efficacy and better treatment algorithm

• Asia Pacific region grown at the fastest rate, owing huge un-tapped population and better patient awareness

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

𝐅𝐥𝐨𝐰 𝐂𝐲𝐭𝐨𝐦𝐞𝐭𝐫𝐲 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/flow-cytometry-market

𝐒𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐑𝐨𝐛𝐨𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/surgical-robot-market

𝐁𝐢𝐨𝐚𝐧𝐚𝐥𝐲𝐭𝐢𝐜𝐚𝐥 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/bioanalytical-testing-services-market

𝐀𝐧𝐭𝐢𝐛𝐢𝐨𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analysis/antibiotics-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:

Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.